Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
29.3%
% of XPH's 43 holdings also in PPH
50.0%
% of PPH's 27 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 4.2% | 5.0% | 4.2% |
|
ZOETIS INC | 3.9% | 4.7% | 3.9% |
|
JOHNSON & JOHNSON | 3.9% | 6.4% | 3.9% |
|
PFIZER INC | 3.7% | 4.6% | 3.7% |
|
ELI LILLY & CO | 3.6% | 12.9% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
|
AXSOME THERAPEUTICS, INC. | 4.5% |
|
CORCEPT THERAPEUTICS INC | 4.2% |
|
INTRA-CELLULAR THERAPIES INC | 4.0% |
|
ROYALTY PHARMA PLC CLASS A | 3.5% |
 |
PERRIGO CO | 3.0% |
|
CATALENT INC | 2.9% |
|
CASSAVA SCIENCES, INC. | 2.9% |
|
ARVINAS, INC. | 2.9% |
|
OCULAR THERAPEUTIX INC | 2.8% |
|
ORGANON & CO. | 2.7% |
XPH Underweight Relative to PPH
|
ELI LILLY & CO | -9.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | -8.6% |
|
ABBVIE INC | -6.0% |
 |
NOVARTIS AG-ADR | -5.3% |
 |
SANOFI-AVENTIS-ADR | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
|
AMERISOURCEBERGEN CORP | -4.3% |
|
MCKESSON CORP | -3.7% |